Shares of Amgen Inc. AMGN inched 0.19% higher to $264.49 Tuesday, on what proved to be an all-around positive trading session ...

The most recent trading session ended with Amgen (AMGN) standing at $264, reflecting a +0.24% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.73%.

Amgen is also growing its local footprint with a second drug substance manufacturing facility at its 109-acre campus in Holly ...

Major League Baseball, active rosters expand to 28 players. 4-7 _ Men’s golf, DP World Tour, The Amgen Irish Open, Kildare, Ireland. 4-14 _ Boxing, World Boxing Championship, Liverpool, England. 5-7 _ ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $263.38 which represents a slight increase of $2.19 or 0.84% from the prior close of $261.19. The stock opened at $269 and touched a low ...

We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options ...

Stagnant sales for Bristol Myers Squibb’s Sotyktu have raised questions about whether the tyrosine kinase 2 (TYK2) inhibitor ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...

The top legal stories in biosimilars from 2024 emphasize the ongoing struggle between ensuring timely patient access and ...

Truist Financial analyst Srikripa Devarakonda has maintained their bullish stance on KROS stock, giving a Buy rating on December 16.Don't Miss ...